我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

人工生物心脏瓣膜的研究进展

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2010年第2期
页码:
157-160
栏目:
基础研究
出版日期:
2010-03-04

文章信息/Info

Title:
-
作者:
易定华
第四军医大学西京医院心血管外科，陕西 西安 710032
Author(s):
-
关键词:
心脏瓣膜; 生物; 人工; 进展
Keywords:
-
分类号:
R542.5
DOI:
-
文献标识码:
A
摘要:
-
Abstract:
-

参考文献/References

［1］ Zilla P, Brink J, Human P. Prosthetic heart valves: Catering for the few［J］. Biomaterials, 2008, 29(4):385-406.

［2］ Krahn AD, Healey JS, Simpson CS, et al. Anticoagulation of patients on chronic warfarin undergoing arrhythmia device surgery: wide variability of perioperative bridging in Canada［J］. Heart Rhythm, 2009, 6(9):1276-1279.

［3］ Ennker JA, Ennker IC, Albert AA, et al. Florath I.The Freestyle stentless bioprosthesis in more than 1000 patients: a single-center experience over 10 years［J］. J Card Surg, 2009, 24(1):41-48.

［4］ Borger MA, Carson SM, Ivanov J, et al. Stentless aortic valves are hemodynamically superior to stented valves during midterm follow-up: a large rest respective study［J］. Ann Thorac Surg, 2005, 80(6):2180-2185.

［5］ Pavoni D, Badano LP, Ius F, et al. Limited long-term durability of the Cryolife OBrien stentless porcine xenograft valve［J］. Circulation, 2007, 116 (11 Suppl):I307-I313.

［6］ Gross JM.Calcification of bioprosthetic heart valve and its assessment［J］. J Thorac Cardiovasc Surg, 2001, 121(3):428-430.

［7］ Eberl T, Siedler S, Schumacher B, et al. Experimental in vitro endothelialization of cardiac valve leaflets［J］. Ann Thorac Surg, 1992, 53(3):487-492.

［8］ 易定华，刘维永，王伯云,等. 减轻异种(猪)主动脉瓣钙化的实验研究［J］. 中华胸心血管外科杂志, 1988, 4(1):48-51.

［9］ 易定华，刘维永. 生物心脏瓣膜钙化机理及抗钙化研究［J］. 中华外科杂志, 1996, 34(10):631-633.

［10］Trowbridge EA, Lawford PV, Crofts CE, et al. Pericardial heterografts: Why do these valves fail?［J］. Thorac Cardiovasc Surg, 1988, 95(4):577-585.

［11］Jamieson WR, Janusz MT, MacNab J, et al. Hemodynamic comparison of second- and third-generation stented bioprostheses in aortic valve replacement［J］. Ann Thorac Surg, 2001, 71(5 Suppl):S282-S284.

［12］Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study［J］. Circulation, 2006, 114(15):1616-1624.

［13］Wenaweser P, Buellesfeld L, Gerckens U, et al. Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: the first valve in valve procedure using the Corevalve Revalving system［J］. Catheter Cardiovasc Interv, 2007, 70(5):760-764.

［14］Webb JG. Percutaneous aortic valve replacement will become a common treatment for aortic valve disease［J］. JACC Cardiovasc Interv, 2008, 1(2):122-126.

［15］Shinoka T, Breuer CK, Tanel RE, et al. Tissue engineering heart valves: valve leaflet replacement study in a lamb model［J］. Ann Thorac Surg, 1995, 60 (6 Suppl):S513-S516.

［16］Hoerstrup SP, Kadner A, Melnitchouk S, et al. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells［J］. Circulation, 2002, 106 (12 Suppl):I143-I150.

［17］顾春虎，刘维永.去细胞支架材料构建组织工程心脏瓣膜研究进展［J］. 心肺血管病杂志， 2005, 24(4)：247-249.

［18］Dohmen PM, Lembcke A, Holinski S, et al. Mid-term clinical results using a tissue engineered pulmonary valve to reconstruct the right ventricular outflow tract during the Ross procedure［J］. Ann Thorac Surg, 2007, 84(3):729-736.

［19］Dong X, Wei X, Yi W, et al. RGD-modified acellular bovine pericardium as a bioprosthetic scaffold for tissue engineering［J］. J Mater Sci Mater Med, 2009, 20(11):2327-2336.

［20］Gu CH, Zhen RH, Yang ZF, et al. Novel glycidyl methacrylated dextran/gelatin nanoparticles loaded with basic fibroblast growthfactor:formulationand characteristics［J］. Drug Development and Industrial Pharmacy, 2009, 35(12):1419-1429.

［21］Wu X, Wei X, Gu C, et al. Optimisation of Dex-GMA nanoparticles prepared in modified micro-emulsion system: Physical and biologic characterization［J］. J Biotechnol, 2009, 143(4):268-273.

［22］顾春虎，易定华，王云雅,等. 动态仿生脉动反应器: 中国实用新型专利200802216284［P］. 2008-02-21.

［23］Liu Y, Liu W, Sun G, et al. Calcification resistance of procyanidin-treated decellularized porcine aortic valves in vivo［J］. Heart Surg Forum, 2009, 12(1):E24-E29.

［24］顾春虎，王云雅，易定华,等. 内皮祖细胞和去细胞猪主动脉瓣构建组织工程瓣膜的研究［J］. 中华实验外科杂志, 2007, 24(3):263-264.

备注/Memo

备注/Memo:
收稿日期：2009-11-30.作者简介：易定华，教授、主任医师、博士生导师，政府特殊津贴享受者，心血管外科主任，中国医师协会心血管外科分会副主任委员，陕西省胸心血管外科分会主任委员和《心脏杂志》副主编等。先后主持国家“八五”科技攻关、“863”重大专项、国家十五科技攻关、国家支撑计划项目、国家自然科学基金等多项国家课题，获国家科技进步二等奖和国家“八五”攻关重大科技成果奖和多项国际和国家专利，主要从事复杂先心病、心肺移植、重症瓣膜病和冠心病外科治疗等研究Email:yidh@fmmu.edu.cn
更新日期/Last Update: 2010-03-05